EUVIMEDOpdag EUVIMED
Randomisierte kontrollierte StudieStudienprotokollOpen access

A Culturally Tailored Mobile Health Intervention to Improve Quality of Life in Black Survivors With Prostate Cancer: Protocol for a Stratified Randomized Controlled Trial

Gaurav Kumar iD, Parisa Ghasemi iD, Adam C Alexander iD, Kathleen Dwyer iD, Jordan M Neil iD, Perry Cole iD, Patrick Beckford iD, Donald Reese iD, Everett Montgomery iD, Roland Odeleye iD, Mark A Harris iD, Yan D Zhao iD and 12 more

JMIR Research Protocols · 2026

DOI: 10.2196/81503 ↗

At a glance

Randomisierte kontrollierte Studie in JMIR Research Protocols, 2026. Written by Gaurav Kumar and 23 co-authors. Institution: TSET Health Promotion Research Center, University of Oklahoma Health Campus, Oklahoma City, OK, United States. Major MEDLINE topics: Prostatic Neoplasms, Quality of Life, Cancer Survivors, Black or African American. Cited 1 times so far (Crossref); 76 references. The full text is freely available in PubMed Central. Funded by: Department of Defense, NIMHD NIH HHS, NCI NIH HHS.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Background

Prostate cancer (CaP) disproportionately affects Black men in the United States, leading to significant disparities in incidence, survival, and quality of life (QoL). Treatment-related side effects, including urinary dysfunction, pain, fatigue, and psychological distress, contribute to poor long-term outcomes. There is an urgent need for culturally-tailored, technology-based interventions to support symptom self-management and survivorship care.

Objective

This study aims to develop, refine, and evaluate the Survivorship App for Ethnically Diverse Black Prostate Cancer Survivors (SAFE-CaPS), a tailored mobile health intervention designed to enhance QoL, improve symptom self-management, and provide psychosocial support.

Methods

This 12-month stratified randomized clinical trial will enroll 248 Black survivors with CaP (including native born, African-born, and Caribbean-born men) into the SAFE-CaPS intervention arm and standard care (SC) control group (1:1 allocation). Eligible participants are self-identified Black men (including native born, African-born, and Caribbean-born) aged 40 to 80 years with a confirmed CaP diagnosis within the past 5 years who own or are willing to use a smartphone. SC will consist solely of routine oncology or primary care follow-up, including clinic visits, referrals, and supportive services as needed, with no digital components. The SAFE-CaPS intervention, developed using the Insight platform, includes daily and weekly ecological momentary assessments of pain, urinary and bowel symptoms, sleep, fatigue, sexual function, mood, physical activity, and diet; adaptive educational modules addressing treatment-related side effects and culturally grounded survivorship concerns; automated symptom alerts prompting nurse follow-up and provider notification; and engagement features such as reminders, goal-setting, and literacy-appropriate content. Intervention content incorporates culturally tailored messaging, patient narratives, and feedback from prior qualitative work with ethnically diverse Black CaP. Stratified randomization will ensure balanced representation of ethnic subgroups. Primary outcomes include overall QoL. Secondary outcomes include specific symptom domains, mental health (depression and anxiety), health care engagement, and app acceptability. Assessments will occur at baseline, 3, 6, 9, and 12 months, and linear mixed models with intent-to-treat principles will evaluate intervention effects over time.

Results

The study was funded in 2024, institutional review board approval was received in mid-2024, and the study began recruitment on August 24, 2025. Overall, 6 participants have been enrolled, with 2 in the SAFE-CaPS intervention and 4 in SC. Recruitment is expected to conclude in July 2027. Data analysis will occur in late 2027, with article preparation and publication planned for mid-2028 and early 2029. We hypothesize that SAFE CaPS participants will experience greater improvements in QoL, reduced symptom burden, and higher engagement in care compared to SC.

Conclusions

This study will provide critical evidence on the feasibility, acceptability, and preliminary effectiveness of a culturally tailored mobile health intervention designed to enhance survivorship outcomes among Black survivors with CaP, informing future large-scale trials and real-world implementation. Trial Registration ClinicalTrials.gov NCT06651359; https://clinicaltrials.gov/study/NCT06651359 International Registered Report Identifier (IRRID) PRR1-10.2196/81503

Subjects

MeSH terms (MEDLINE)

Prostatic NeoplasmsQuality of LifeCancer SurvivorsBlack or African AmericanMobile ApplicationsHumansMaleRandomized Controlled Trials as TopicAgedMiddle AgedTelemedicineAdultAged, 80 and overCulturally Competent Care

Author keywords

Black mencancer survivorshipculturally-tailored interventionsmobile healthprostate cancerquality of lifesymptoms monitoring

Authors and institutions

  • TSET Health Promotion Research Center, University of Oklahoma Health Campus, Oklahoma City, OK, United States.
  • Department of Family and Preventive Medicine, University of Oklahoma Health Campus, Oklahoma City, OK, United States.
  • Fran and Earl Ziegler College of Nursing, University of Oklahoma Health Campus, Oklahoma City, OK, United States.
  • The Multidisciplinary Health Outcomes Research and Economics (MORE) Lab Community Advisory Board, University of Oklahoma Health Campus, Oklahoma City, OK, United States.
  • Department of Biostatistics and Epidemiology, Hudson College of Public Health, University of Oklahoma Health Campus, Oklahoma City, OK, United States.
  • Department of Urology, Stephenson Cancer Center, University of Oklahoma Health Campus, Oklahoma City, OK, United States.

ORCID profiles: Gaurav Kumar, Parisa Ghasemi, Adam C Alexander, Kathleen Dwyer, Jordan M Neil, Perry Cole, Patrick Beckford, Donald Reese, Everett Montgomery, Roland Odeleye, Mark A Harris, Yan D Zhao, Zsolt Nagykaldi, Andrew G McIntosh, Ernie Kaninjing, Mary E Young, Sabrina Dickey, Daniel J Morton, Opeyemi Bolajoko, Folakemi T Odedina, Lourdes G Planas, Michael S Businelle, Darla E Kendzor, Motolani E Ogunsanya

Funding

  • Department of Defense
  • NIMHD NIH HHS
  • NCI NIH HHS

Cite

APA

Kumar, G., Ghasemi, P., Alexander, A. C., Dwyer, K., Neil, J. M., Cole, P., Beckford, P., Reese, D., Montgomery, E., Odeleye, R., Harris, M. A., Zhao, Y. D., Nagykaldi, Z., McIntosh, A. G., Kaninjing, E., Young, M. E., Dickey, S., Morton, D. J., Bolajoko, O., …, & Ogunsanya, M. E. (2026). A Culturally Tailored Mobile Health Intervention to Improve Quality of Life in Black Survivors With Prostate Cancer: Protocol for a Stratified Randomized Controlled Trial. JMIR Research Protocols. https://doi.org/10.2196/81503

Vancouver

Kumar G, Ghasemi P, Alexander AC, Dwyer K, Neil JM, Cole P, et al. A Culturally Tailored Mobile Health Intervention to Improve Quality of Life in Black Survivors With Prostate Cancer: Protocol for a Stratified Randomized Controlled Trial. JMIR Research Protocols. 2026. doi:10.2196/81503

BibTeX
@article{Kumar2026,
  author = {Kumar, Gaurav and Ghasemi, Parisa and Alexander, Adam C and Dwyer, Kathleen and Neil, Jordan M and Cole, Perry and Beckford, Patrick and Reese, Donald and Montgomery, Everett and Odeleye, Roland and Harris, Mark A and Zhao, Yan D and Nagykaldi, Zsolt and McIntosh, Andrew G and Kaninjing, Ernie and Young, Mary E and Dickey, Sabrina and Morton, Daniel J and Bolajoko, Opeyemi and Odedina, Folakemi T and Planas, Lourdes G and Businelle, Michael S and Kendzor, Darla E and Ogunsanya, Motolani E},
  title = {A Culturally Tailored Mobile Health Intervention to Improve Quality of Life in Black Survivors With Prostate Cancer: Protocol for a Stratified Randomized Controlled Trial},
  journal = {JMIR Research Protocols},
  year = {2026},
  doi = {10.2196/81503}
}
Start for free →